Company intelligence / Profile preview

Artgen Biotech

Moscow, Moscow, RUSSIAN FEDERATIONartgen.ru ↗
Ownership
Private
Development stage
Other
01

Overview

Artgen Biotech (formerly Human Stem Cell Institute) is a leading Russian biotech company with commercialized offerings in regenerative medicine, medical genetics, gene therapy drugs, tissue engineering products, and bio-insurance. It operates major biobanking businesses for cord blood and reproductive cells. The group also develops innovative therapies for orphan and socially significant diseases using proprietary platforms such as gene‐activated matrices. Some R&D programs target primary immunodeficiencies or use novel technologies like human artificial chromosomes or polysialic acid-based drugs. The company is publicly traded on the Moscow Exchange.

Therapeutic areas
ImmunologyOtherCardiovascularRare Diseases
Modalities
Gene therapyCell therapyTissue engineering productRecombinant proteinGenetic testing and counseling services
Industry
Biotech
02

Drug pipeline

5 assets

Neovasculgen variant 5

Preclinical

4 more assets in the full pipeline.

Beyond the preview

Go deeper on Artgen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artgen Biotech.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call